POSTER: ABCL-853: Vispa-Cel, an Allogeneic Anti-CD19 CAR-T Therapy With a PD-1 Knockout, in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (ANTLER Phase 1 Clinical Trial)

Mohamad Cherry; Houston Holmes; James Essell; Ayad Hamdan; Boyu Hu; Elizabeth Brem; Rushang D Patel; Sunita Nasta; Costas K Yannakou; Don A Stevens; Umar Farooq; Kenneth Micklethwaite; Vamsi Kota; Abraham S Kanate; Tatyana Feldman; Melhem M Solh; David Lavie; Benedict Carnley; Muhammad Husnain; Cesar Gentille Sanchez; Fevzi Yalniz; Gary L Simmons; Donna Marcy; Erin Mullane; Jim Peck; Chris Holland; Ashraf Garrett; Govind Shah; Pingping Mao; Eric W Stawiski; Enrique Zudaire; Tonia Nesheiwat; Maria do Socorro Oliviera Portella; Stephen J Schuster; Loretta J Nastoupil; Susan O'Brien; Mehdi Hamadani

doi:10.1016/S2152-2650(26)01121-3

$POSTER: ABCL-853: Vispa-Cel, an Allogeneic Anti-CD19 CAR-T Therapy With a PD-1 Knockout, in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (ANTLER Phase 1 Clinical Trial)$

Abstract

Peer reviewed

POSTER: ABCL-853: Vispa-Cel, an Allogeneic Anti-CD19 CAR-T Therapy With a PD-1 Knockout, in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (ANTLER Phase 1 Clinical Trial)

Mohamad Cherry, Houston Holmes, James Essell, Ayad Hamdan, Boyu Hu, Elizabeth Brem, Rushang D Patel, Sunita Nasta, Costas K Yannakou, Don A Stevens, …

Clinical lymphoma, myeloma and leukemia, Vol.26(Suppl 1), pp.S308-S308

08/2026

DOI: 10.1016/S2152-2650(26)01121-3

View Online

Details

Title: Subtitle: POSTER: ABCL-853: Vispa-Cel, an Allogeneic Anti-CD19 CAR-T Therapy With a PD-1 Knockout, in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (ANTLER Phase 1 Clinical Trial)
Creators: Mohamad Cherry - Atlantic Health System
Houston Holmes - Texas Oncology
James Essell - Cincinnati Cancer Advisors, Cincinnati, OH, USA
Ayad Hamdan - University of California San Diego
Boyu Hu - University of Utah
Elizabeth Brem - University of California, Irvine
Rushang D Patel - AdventHealth Orlando
Sunita Nasta - University of Pennsylvania
Costas K Yannakou - Epworth Hospital
Don A Stevens - Norton Healthcare
Umar Farooq - University of Iowa
Kenneth Micklethwaite - Westmead Hospital
Vamsi Kota - Augusta University
Abraham S Kanate - HonorHealth
Tatyana Feldman - Hackensack Meridian Health
Melhem M Solh - Northside Hospital
David Lavie - Hadassah Medical Center
Benedict Carnley - Royal Perth Hospital
Muhammad Husnain - University of Arizona
Cesar Gentille Sanchez - Arkansas Department of Agriculture
Fevzi Yalniz - University of Kentucky
Gary L Simmons - Virginia Oncology Associates
Donna Marcy - Caribou Biosciences (United States)
Erin Mullane - Caribou Biosciences (United States)
Jim Peck - Caribou Biosciences (United States)
Chris Holland - Caribou Biosciences (United States)
Ashraf Garrett - Caribou Biosciences (United States)
Govind Shah - Caribou Biosciences (United States)
Pingping Mao - Caribou Biosciences (United States)
Eric W Stawiski - Caribou Biosciences (United States)
Enrique Zudaire - Caribou Biosciences (United States)
Tonia Nesheiwat - Caribou Biosciences (United States)
Maria do Socorro Oliviera Portella - Caribou Biosciences (United States)
Stephen J Schuster - University of Pennsylvania
Loretta J Nastoupil - Mercy Regional Medical Center
Susan O'Brien - University of California, Irvine
Mehdi Hamadani - Medical College of Wisconsin
Resource Type: Abstract
Publication Details: Clinical lymphoma, myeloma and leukemia, Vol.26(Suppl 1), pp.S308-S308
DOI: 10.1016/S2152-2650(26)01121-3
ISSN: 2152-2650
Publisher: Elsevier Inc
Language: English
Date published: 08/2026
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
Record Identifier: 9985222746202771

Metrics

1 Record Views